Safety and Effectiveness of Rasburicase in the Control of Hyperuricemia in Pediatric Patients with Non-Hodgkin's Lymphoma and Acute Leukemia: An Open-Label, Single-Arm, Multi-center, Interventional Study.
Saved in:
| Title: | Safety and Effectiveness of Rasburicase in the Control of Hyperuricemia in Pediatric Patients with Non-Hodgkin's Lymphoma and Acute Leukemia: An Open-Label, Single-Arm, Multi-center, Interventional Study. |
|---|---|
| Authors: | Wang, Tianyou1 (AUTHOR) wangtianyou@bch.com.cn, Zhu, Xiaofan2 (AUTHOR), Chen, Yumei2 (AUTHOR), Shen, Shuhong3 (AUTHOR), Tang, Yongmin4 (AUTHOR), Zhang, Jingying4 (AUTHOR), He, Yingyi5 (AUTHOR), Zhang, Hui5 (AUTHOR), Gao, Ju6 (AUTHOR), Fang, Jianpei7 (AUTHOR), Liu, Rong8 (AUTHOR), Wu, Xiaoyan9 (AUTHOR), Sun, Jinchuan10 (AUTHOR), Zhang, Minlu10 (AUTHOR) |
| Source: | Drugs in R&D. Jun2023, Vol. 23 Issue 2, p129-140. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
